IMPACT BIOMEDICAL INC. Operating Income Loss

Quick Answer

IMPACT BIOMEDICAL INC. reported Operating Income Loss of -$4.28 million for the year ending 2025.

  • IMPACT BIOMEDICAL INC. showed an increase of +85.1% in Operating Income Loss from 2024 to 2025.
  • This data is from IMPACT BIOMEDICAL INC.'s annual report (Form 10-K), filed with the SEC on March 11, 2026.
  • XBRL data for this metric is available from 2022 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 4 years of available data (2022 to 2025), IMPACT BIOMEDICAL INC.'s Operating Income Loss has declined by 25.8%.
  • Historical annual values: Fiscal year 2025: -$4.28 million | Fiscal year 2024: -$28.75 million | Fiscal year 2023: -$4.03 million | Fiscal year 2022: -$3.40 million.
  • Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: